Literature DB >> 9377723

Endothelin: a mediator of renal disease progression.

I Bruzzi1, G Remuzzi, A Benigni.   

Abstract

Glomerulosclerosis and tubulointerstitial damage are characteristics of progressive renal diseases associated with chronic proteinuria. Since numerous studies have demonstrated a correlation between proteinuria and the degree of renal damage, a causal role for proteinuria in the development of progressive renal failure has been postulated. Some in vitro data suggest that endothelins (ET), a family of endogenous peptides, could be involved in the genesis and progression of glomerular damage. Moreover, evidence that tubular cells exposed to high molecular weight proteins are induced to release ET toward the basolateral compartment, together with the capability of these peptides to influence events occurring in the interstitium, suggest that ET could also participate in interstitial inflammation. Data are now available that ET actually plays a role in the progression of chronic renal disease in different experimental models including renal mass reduction, lupus nephritis and streptozotocin-induced diabetes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9377723

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  7 in total

1.  Histochemical distribution of endothelin-converting enzyme subtypes in Podarcis sicula (Squamata, Lacertidae) tissues.

Authors:  Salvatore Valiante; Marina Prisco; Maria De Falco; Francesca Virgilio; Rosaria Sciarrillo; Piero Andreuccetti; Vincenza Laforgia; Lorenzo Varano
Journal:  J Anat       Date:  2005-10       Impact factor: 2.610

2.  Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

Authors:  Davide Bolignano; Antonio Lacquaniti; Giuseppe Coppolino; Valentina Donato; Susanna Campo; Maria Rosaria Fazio; Giacomo Nicocia; Michele Buemi
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

3.  Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach.

Authors:  K Kanková; A Stejskalová; L Pácal; S Tschoplová; M Hertlová; D Krusová; L Izakovicová-Hollá; M Beránek; A Vasků; S Barral; J Ott
Journal:  Diabetologia       Date:  2007-03-08       Impact factor: 10.122

4.  Methods to evaluate the effect of ethanol on the folate analogue: fluorescein methotrexate uptake in human proximal tubular cells.

Authors:  Sivakumar Jt Gowder; Kenneth E McMartin
Journal:  Adv Pharmacol Sci       Date:  2009-09-29

5.  Endothelin A receptor antagonist, atrasentan, attenuates renal and cardiac dysfunction in Dahl salt-hypertensive rats in a blood pressure independent manner.

Authors:  Mohammed A Samad; Ui Kyoung Kim; Joshua J Kang; Qingen Ke; Peter M Kang
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

6.  Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.

Authors:  Basma Ismail; Rob A deKemp; Etienne Croteau; Tayebeh Hadizad; Kevin D Burns; Rob S Beanlands; Jean N DaSilva
Journal:  PLoS One       Date:  2017-05-19       Impact factor: 3.240

7.  Endothelin signaling regulates mineralization and posttranscriptionally regulates SOST in TMOb cells via miR 126-3p.

Authors:  Michael G Johnson; Kathryn Konicke; Jasmin Kristianto; Anne Gustavson; Rachel Garbo; Xiaohu Wang; Baozhi Yuan; Robert D Blank
Journal:  Physiol Rep       Date:  2017-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.